284 related articles for article (PubMed ID: 23056032)
41. Cryptococcosis-IRIS is associated with lower cryptococcus-specific IFN-γ responses before antiretroviral therapy but not higher T-cell responses during therapy.
Chang CC; Lim A; Omarjee S; Levitz SM; Gosnell BI; Spelman T; Elliott JH; Carr WH; Moosa MY; Ndung'u T; Lewin SR; French MA
J Infect Dis; 2013 Sep; 208(6):898-906. PubMed ID: 23766525
[TBL] [Abstract][Full Text] [Related]
42. [Cryptococcal meningitis in children: description of 3 cases].
Ndiaye M; Diagne NR; Seck LB; Sow AD; Sène MS; Diop AG; Sow HD; Ndiaye MM
Med Trop (Mars); 2011 Apr; 71(2):176-8. PubMed ID: 21695878
[TBL] [Abstract][Full Text] [Related]
43. Immune-related neurodegeneration in the midbrain causes pulmonary dysfunction in murine cryptococcal IRIS.
Dangarembizi R; Drummond R
Trends Neurosci; 2023 Dec; 46(12):1003-1004. PubMed ID: 37806831
[TBL] [Abstract][Full Text] [Related]
44. Liposomal amphotericin B for a case of intractable cryptococcal meningoencephalitis and immune reconstitution syndrome.
Sasakawa A; Yamamoto Y; Yajima K; Sakai M; Uehira T; Shirasaka T; Makie T
J Med Invest; 2008 Aug; 55(3-4):292-6. PubMed ID: 18797146
[TBL] [Abstract][Full Text] [Related]
45. Clinical and mycological predictors of cryptococcosis-associated immune reconstitution inflammatory syndrome.
Chang CC; Dorasamy AA; Gosnell BI; Elliott JH; Spelman T; Omarjee S; Naranbhai V; Coovadia Y; Ndung'u T; Moosa MY; Lewin SR; French MA
AIDS; 2013 Aug; 27(13):2089-99. PubMed ID: 23525034
[TBL] [Abstract][Full Text] [Related]
46. Burden of cryptococcal meningitis in Malawi.
Makombe SD; Nkhata A; Schouten EJ; Kamoto K; Harries AD
Trop Doct; 2009 Jan; 39(1):32-4. PubMed ID: 19211421
[TBL] [Abstract][Full Text] [Related]
47. Cryptococcal meningitis in Lilongwe and Blantyre, Malawi.
Maher D; Mwandumba H
J Infect; 1994 Jan; 28(1):59-64. PubMed ID: 8163834
[TBL] [Abstract][Full Text] [Related]
48. Paucity of initial cerebrospinal fluid inflammation in cryptococcal meningitis is associated with subsequent immune reconstitution inflammatory syndrome.
Boulware DR; Bonham SC; Meya DB; Wiesner DL; Park GS; Kambugu A; Janoff EN; Bohjanen PR
J Infect Dis; 2010 Sep; 202(6):962-70. PubMed ID: 20677939
[TBL] [Abstract][Full Text] [Related]
49. Current approach to the acute management of cryptococcal infections.
Powderly WG
J Infect; 2000 Jul; 41(1):18-22. PubMed ID: 11041709
[No Abstract] [Full Text] [Related]
50. Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort study.
Boulware DR; Meya DB; Bergemann TL; Wiesner DL; Rhein J; Musubire A; Lee SJ; Kambugu A; Janoff EN; Bohjanen PR
PLoS Med; 2010 Dec; 7(12):e1000384. PubMed ID: 21253011
[TBL] [Abstract][Full Text] [Related]
51. Prognostic markers in AIDS-related cryptococcal meningitis.
Majumder S; Mandal SK; Bandyopadhyay D
J Assoc Physicians India; 2011 Mar; 59():152-4. PubMed ID: 21751623
[TBL] [Abstract][Full Text] [Related]
52. Cryptococcal meningitis in an immunocompetent patient.
Murphy LS; Lacy AJ; Smith AT; Shah KS
Am J Emerg Med; 2020 Nov; 38(11):2492.e1-2492.e3. PubMed ID: 32534877
[TBL] [Abstract][Full Text] [Related]
53. Cryptococcal meningitis in AIDS.
Spec A; Powderly WG
Handb Clin Neurol; 2018; 152():139-150. PubMed ID: 29604972
[TBL] [Abstract][Full Text] [Related]
54. CNS-immune reconstitution inflammatory syndrome in the setting of HIV infection, part 1: overview and discussion of progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome and cryptococcal-immune reconstitution inflammatory syndrome.
Post MJ; Thurnher MM; Clifford DB; Nath A; Gonzalez RG; Gupta RK; Post KK
AJNR Am J Neuroradiol; 2013 Jul; 34(7):1297-307. PubMed ID: 22790246
[TBL] [Abstract][Full Text] [Related]
55. Response to therapy in patients with cryptococcosis and AIDS: Association with in vitro susceptibility to fluconazole.
Agudelo CA; Muñoz C; Ramírez A; Tobón AM; de Bedout Bact C; Cano LE; Restrepo A
Rev Iberoam Micol; 2015; 32(4):214-20. PubMed ID: 25637338
[TBL] [Abstract][Full Text] [Related]
56. Complex Decisions in HIV-Related Cryptococcosis: Addressing Second Episodes of Cryptococcal Meningitis.
Musubire A; Kagimu E; Mugabi T; Meya DB; Boulware DR; Bahr NC
Curr HIV/AIDS Rep; 2024 Apr; 21(2):75-85. PubMed ID: 38400871
[TBL] [Abstract][Full Text] [Related]
57. 'Time-to-amphotericin B' in cryptococcal meningitis in a European low-prevalence setting: analysis of diagnostic delays.
Katchanov J; von Kleist M; Arastéh K; Stocker H
QJM; 2014 Oct; 107(10):799-803. PubMed ID: 24722846
[TBL] [Abstract][Full Text] [Related]
58. Short-course amphotericin B in addition to sertraline and fluconazole for treatment of HIV-associated cryptococcal meningitis in rural Tanzania.
Katende A; Mbwanji G; Faini D; Nyuri A; Kalinjuma AV; Mnzava D; Hullsiek KH; Rhein J; Weisser M; Meya DB; Boulware DR; Letang E;
Mycoses; 2019 Dec; 62(12):1127-1132. PubMed ID: 31461550
[TBL] [Abstract][Full Text] [Related]
59. A prospective study of AIDS-associated cryptococcal meningitis in Thailand treated with high-dose amphotericin B.
Pitisuttithum P; Tansuphasawadikul S; Simpson AJ; Howe PA; White NJ
J Infect; 2001 Nov; 43(4):226-33. PubMed ID: 11869059
[TBL] [Abstract][Full Text] [Related]
60. Fluconazole penetration into the prostatic fluid of patients with AIDS-associated cryptococcal meningitis.
Luzzati R; Gatti G; Lazzarini L; Limonta D; Vento S; Concia E
J Antimicrob Chemother; 1998 Mar; 41(3):423-4. PubMed ID: 9578176
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
